Analytical quality-by-design based method development for the analysis of StigA8, A new peptide synthetic of the Tityus stigmurus, using UHPLC/MS-ESI TOF

dc.contributor.advisorAragão, Cícero Flávio Soares
dc.contributor.advisorLatteshttp://lattes.cnpq.br/9657118649043311 orcid.org/0000-0002-3434-2602 https://publons.com/researcher/F-2974-2017/pt_BR
dc.contributor.authorSouza, Marina Graziela Costa
dc.contributor.referees1Porto, Dayanne Lopes
dc.contributor.referees2Pedrosa, Matheus de Freitas Fernandes
dc.date.accessioned2025-01-17T14:54:55Z
dc.date.available2025-01-17T14:54:55Z
dc.date.issued2025-01-08
dc.description.resumoStigA8, an antimicrobial peptide analog developed from Stigmurine, was designed to maximize therapeutic efficacy through specific substitutions of lysine residues in its amino acid sequence. These structural modifications aimed to enhance its physicochemical properties and broaden its antimicrobial activity, making it a promising tool in combating resistant infections. This study developed a robust and efficient analytical method for its analysis using the Analytical Quality by Design (AQbD) approach in conjunction with the UHPLC/MS-ESI TOF technique. A full factorial experimental design was applied to evaluate the impact of critical variables such as column length, mobile phase composition, and flow rate. Methods 9, 18, and 27 yielded promising results, all using a 150 mm column and a mobile phase composition of 50%. The differentiating variable among these methods was the flow rate, which ranged from 0.1, 0.2, to 0.3 mL/min, respectively. Pareto and response surface graphs highlighted the relevance of the mobile phase and column for optimizing chromatographic efficiency, retention time, and peak symmetry, whereas the flow had a lesser statistical impact. This study significantly contributes to the analysis of bioactive peptides, offering a practical and innovative tool for quality control in pharmaceutical and biotechnological laboratories.pt_BR
dc.description.sponsorshipCNPQpt_BR
dc.identifier.citationSOUZA, Marina Graziela Costa. Analytical quality-by-design based method development for the analysis of Stiga8, a new peptide synthetic of the Tityus stigmurus, using UHPLC/MS-ESI TOF. Orientador: Cícero Flávio Soares Aragão. 2025. 23 f. Trabalho de Conclusão de Curso (Graduação em Farmácia) – Departamento de Ciências da Saúde, Universidade Federal do Rio Grande do Norte, 2025.pt_BR
dc.identifier.urihttps://repositorio.ufrn.br/handle/123456789/61296
dc.languageenpt_BR
dc.publisherUniversidade Federal do Rio Grande do Nortept_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentDepartamento de Farmáciapt_BR
dc.publisher.initialsUFRNpt_BR
dc.publisher.programFarmáciapt_BR
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Brazil*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/br/*
dc.subjectUHPLCpt_BR
dc.subjectAQbDpt_BR
dc.subjectPeptidept_BR
dc.subjectChromatographypt_BR
dc.subjectStigA8.pt_BR
dc.subject.cnpqCNPQ::CIENCIAS DA SAUDEpt_BR
dc.titleAnalytical quality-by-design based method development for the analysis of StigA8, A new peptide synthetic of the Tityus stigmurus, using UHPLC/MS-ESI TOFpt_BR
dc.title.alternativeAnalytical quality-by-design based method development for the analysis of StigA8, A new peptide synthetic of the Tityus stigmurus, using UHPLC/MS-ESI TOFpt_BR
dc.typebachelorThesispt_BR

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
_TCC - Marina - Final.docx (2).pdf
Tamanho:
1.24 MB
Formato:
Adobe Portable Document Format
Nenhuma Miniatura disponível
Baixar

Licença do Pacote

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.45 KB
Formato:
Item-specific license agreed upon to submission
Nenhuma Miniatura disponível
Baixar